| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $741K | +0.0% |
| Cost of Revenue | $5.0M | -34.1% |
| Gross Profit | $5.4M | -28.9% |
| R&D Expense | $10.4M | +8.3% |
| SG&A Expense | $13.8M | -45.8% |
| Operating Income | -$35.0M | -1.4% |
| Interest Expense | $1.1M | +127.7% |
| Net Income | -$36.0M | -8.5% |
| EPS (Basic) | -$30.73 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $979K | -94.5% |
| Current Assets | $4.0M | -83.6% |
| Total Assets | $18.9M | -62.7% |
| Current Liabilities | $13.3M | +54.9% |
| Total Liabilities | $17.0M | +33.6% |
| Stockholders' Equity | $1.5M | -95.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.5M | +6.8% |
| Capital Expenditures | $292K | -61.2% |
| Investing Cash Flow | -$292K | +98.0% |
| Financing Cash Flow | $1.7M | -96.5% |
| Free Cash Flow | -$19.8M | +8.7% |
| -5.4% |